ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Masaki Saito, Vladimir A. Apse, Vladimir V. Artisyuk, Anatolii N. Chmelev
Nuclear Technology | Volume 133 | Number 2 | February 2001 | Pages 229-241
Technical Paper | Radioactive Waste Management and Disposal | doi.org/10.13182/NT01-A3171
Articles are hosted by Taylor and Francis Online.
Transmutation of radioactive Cs from fission products of nuclear reactors without the potentially dangerous and expensive operation of isotopic separation is addressed. Transmutation is proposed to be performed in the blanket of a fusion neutron source with the plasma performance characteristics inherent in the current research on fusion reactors. The domain of Cs transmutation is quantitatively determined with detailed neutronics analysis of hard and softened neutron spectra, the effect of first wall loading, and two reprocessing modes. One is continuous on-line reprocessing; another one deals with a multicycle option in which a substantially long irradiation period is assumed before reprocessing. Transmutation efficiency is estimated in terms of the effective lifetime of 135Cs, which is the key characteristic governing the approach to equilibrium and the fraction of power associated with cesium transmutation in a nuclear energy system as a whole. In a contrast to fast reactors and accelerator-driven systems, fusion-driven transmutation reveals time to approach equilibrium that is comparable with the lifetime of transmuter and power associated with transmutation lies well within 5% of the total power of the nuclear energy system composed of fission reactors and transmuters.